All Type of News
Government urged to guarantee appropriate level of NHI price
The Korea Pharmaceutical Association in its recent statement criticized the recent government decision to raise the National Health Insurance price by 2.65 percent next year, claiming that the decision has required ar...
Medical circle to resist against NHI price increases and other issues.
The medical circle strongly resisted against the recent government's plan for the NHI price increase in 2004 at 2.65% over this year along with other issues including the medical and pharmacy role separation program t...
Large packaged drugs to investigate its quality.
The Korea Pharmaceutical Association (KPA) is going to request an overall investigation over the large packaged drugs that were suspected of its quality.
The Illicit and Substandard Drug Report Center affiliated ...
Medical community to demand prescription right for functional health foods
Doctors should be entitled to prescribe the dispensing of functional health foods including selling of finished products, according to the recent symposium.
In the symposium hosted by the Medical Policy Institute o...
Civil groups insist on withdrawal of increased medical premiums
Following the government's November 28 decision to raise national medical premiums by 6.75 percent next year, seven civic groups insisted on the freeze of premiums in a statement.
The statement said that the govern...
Whanin Pharm seeking suit to confirm non-presence of liabilities over Merck-Lipha
Whanin Pharm said it is seeking a local court's ruling over the liabilities incurred out of an annulled secrecy agreement executed earlier with France-based Merck-Lipha, while
According to Whanin, the company had ...
Medical/pharmacy circles to oppose 2.56% NHI price increase.
The NHI price and NHI premium in 2004 finally determined to raise merely 2.65% (56.87 won) from this year (55.4 won) and 6.75% respectively.
Under the new pricing scheme the daily pharmacy dispensing fees will be i...
EDI bills to get many privileges in NHI reimbursement.
The Health Insurance Review Agency (HIRA) encouraged the medical bills through the EDI channels with incentive plans including a short review time whereas the review on non-EDI bills be tightened.
The HIRA announce...
Calcium antagonists led domestic antihypertensive market in first half
Calcium antagonists, such as Norvasc, Adalat Oros and Zanidip, led the local antihypertensive drugs market in the first half of this year, according to KPMR report of 120 wholesalers released by Bestcare, drug whole...
Modifications of manufacturing license can be delivered via internet
The Korea Food and Drug Administration announced it would implement a new guideline to disseminate modified information of manufacturing license via internet from this December as part of its efforts to establish the ...
